| Merck: Stockholder Services... account information or viewing the Merck Annual Report or Proxy Statement. ... Final Report of Inspector of Election. Adobe PDF. Stock Investment Plan ...Merck Stock Report (MRK) | Quote & News... valuations, financial statements, estimates and ownership information on Merck. ... Fund Products Stock Products ETF Products Personal Finance Products Workshops ...Merck 2005 Annual Report - Corporate informationDirect Purchase of Merck Stock and Dividend Reinvestment Plan. You can purchase shares directly from the Company through the Merck Stock Investment Plan. ...Merck & Co Stock | S&P ReportPrice: $35 | Standard & Poor's Merck & Co Stock Report offers up-to-date, reliable data & objective analysis, prepared by our team of highly regarded analysts.Report: Merck Played Down Vioxx Risks<I>The Wall Street Journal</I> says company documents show ... Stock News : Biotech/Pharmaceuticals. Report: Merck Played Down Vioxx Risks. By TSC Staff ...Merck Stock Report (MRK) | Snapshot... valuations, financial statements, estimates and ownership information on Merck. ... Fund Products Stock Products ETF Products Personal Finance Products Workshops ...Merck Stock Report (MRK) | Data Interpreter... valuations, financial statements, estimates and ownership information on Merck. ... Fund Products Stock Products ETF Products Personal Finance Products Workshops ...MRK: Summary for MERCK CO INC - Yahoo! Finance... detailed information on MERCK CO INC (MRK) ... Annual Report for MRK ... "STOCK MARKET WATCH 3-day Forecast from Monday Nov 6, 2006 OF MAIN AND SECTOR...Merck report hits stock hard - Pittsburgh Tribune-ReviewMerck & Co. ... Merck report hits stock hard. Business. Market Indexes. Market Summary. Read All Top Business ... New York Stock Exchange, Merck stock was down ...1998 Merck Annual Report/Corporate InformationMerck stock or dividends, call us toll-free at (800)613-2104. Annual Meeting ... Direct Purchase of Merck Stock. You can purchase shares directly from the ...relatedMRK: Summary for MERCK CO INC - Yahoo! FinanceGet detailed information on MERCK CO INC (MRK) including quote performance, Real-Time ECN, technical chart analysis, key stats, insider ...Merck Stock Report (MRK) | Quote & NewsGet quotes, news, returns, research and ratings, as well as charts, valuations, financial statements, estimates and ownership information on Merck.Merck Stock Report (MRK) | OwnersGet quotes, news, returns, research and ratings, as well as charts, valuations, financial statements, estimates and ownership information on Merck.Merck stock plunges on report of damaging e-mailsMerck stock plunges on report of damaging e-mails ... Shares of Merck & Co. plunged Monday after a news report suggested that the ...Merck stock slips after negative journal reportMerck stock slips after negative journal report ... In a statement, Merck disagreed with The Lancet's report, saying it was "vigilant ...Merck Stock Tumbles on Vioxx ReportMerck Stock Tumbles on Vioxx Report ... ... seriously injured by Vioxx may be significantly higher than originall though, Merck's stock ...The Seattle Times: Biotech: Stock plummets on report Merck knew of ...Stock plummets on report Merck knew of Vioxx risk ... — Shares of Merck plunged about 10 percent yesterday after a media report said ...Merck & Co., Inc. Stock Quotes, News, MRK Stock Chart, Report ...MRK Stock Trading: MRK stock quote MRK stock charts MRK stock news MRK stock financial reports, earnings for Merck & Co., Inc.relatedStocks to Watch, Nov. 8: Sirius, Novell and MerckBarr Pharmaceuticals Inc. is expected to report earnings per share for the first quarter of 74 cents, according to analysts polled by Thomson First Call. Stocks expected to move Wednesday... whose shares are expected to see active trade in Wednesday's session are Sirius Satellite Radio Inc., Novell Inc. and Merck & Co. Barr Pharmaceuticals Inc. ( BRL : BRL Sponsored by: , , ) is expected to report earnings per share for the first ... Cyanide Poisoning Poses Threat to Health, Safety... at the American Public Health Association Annual Meeting, was funded by EMD Pharmaceuticals, the U.S. affiliate of Merck KGaA, Darmstadt, Germany and included survey responses from more than 500 emergency medical services (EMS) providers and ... Abbott to acquire rivalMoving to attack one of the world's biggest health-care problems and make money in the pharmaceutical industry's most lucrative sector, Abbott Laboratories on Monday said it will pay $3.7 billion in cash for a ... Breaking the Chain... antimonopoly tradition. We see it in the most vital statement on industry in American history, Alexander Hamilton's Report on Manufactures, itself deeply influenced by Adam Smith's antimonopoly writings in The Wealth of Nations. We see its ... Abbott Pays 56% Premium for Kos Pharma... a share in cash for Kos, Cranbury, N.J. That represents a 55% premium from Kos's Friday closing price of $50.09. The stock shot up $26.90, or 54%, to $76.99 in recent trading. Abbott's shares were recently trading at $47.46, down 18 cents. Analysts ... Takeda Cuts Profit Forecast After Second-Quarter Earnings Drop 47 Percent... in the year ending March 2007, from a record 313.2 billion yen a year earlier, Takeda said in a statement to the Tokyo Stock Exchange today. It predicted a 2.2 percent increase in July. Actos, which accounts for about a quarter of the Osaka-based ... If you're looking for a good idea, steal one... the funds' reports. The managers are in no way responsible for my picks - and in some cases, may even have sold the stock I chose to steal. In the past six years, my 'Purloined Portfolio' has posted an average return of 21 percent, compared to 3.5 ... Makers, Sellers and Managers of Drugs Do Deals... another guilty plea, one major new case filed, a former chief executive sentenced to prison and a critical report by regulators that may lead to civil or even criminal charges against one of the world's biggest oil companies. POWERFUL MEDICINE In a ... Medco 3Q profit rises, boosts outlook 5:10 PM Et... per share, a year ago. Excluding 9 cents per share for write-downs of contracts Medco got when spun off by drugmaker Merck & Co. in 2003, Medco posted a profit of 71 cents per share. Analysts polled by Thomson Financial expected earnings per share ... The Business Week in Review... in October, the smallest gain for the worlds largest retailer in nearly six years. Tuesday Whitehouse Station-based Merck will pay $1 billion for the San Francisco biotech Sima Therapeutics. ... Trump Entertainment Resorts, which owns three of the ... Analysis: Alnylam taking lead in RNAiAlnylam's third-quarter earnings beat Wall Street's expectations and the company is fast emerging as the leader in the RNAi space, since Sirna is being acquired by Merck. A little biotech's big, risky bet on weight loss... potential billion-dollar-plus franchise," wrote Jim Reddoch, analyst for Friedman, Billings, Ramsey, in a recent report. Reddoch rates Amylin a "buy," and expects the stock price to jump by a third over the next year. The stock has already tripled ... The Web Doctor Is In... publishing business that produces a physician directory and medical reference texts). In its third-quarter earnings report Thursday night, the company said its WebMD Health Network averaged 32.2 million unique users a month, an increase of about 30% ... Medco Earnings Rise 19 Percent on Sales of Generic and Biotechnology Drugs... between drugmakers and health insurance plans, capitalized on patent expirations for Pfizer Inc.'s Zoloft and Merck & Co.'s Zocor, allowing sales of less-expensive pills at higher markups. Shares of Medco have declined 5.2 percent since CVS Corp. ... : Ticking up before employment data... If it was economic indicators, oil prices or earnings, every day (even if the market ticked higher at the beginning), stock markets closed down for five sessions in a row . Well, this morning is no different and the bulls will give it one last shot ... Commerzbank Profit Declines 17 Percent on Added Provisions for Risky Loans... second quarter, expectations weren't very high and the bank fulfilled them,'' said Konrad Becker, an analyst at Merck Finck in Munich. ``It's positive that commission income was higher than expected. Going forward, Commerzbank needs to change its ... Analysis: Analysts mixed on AltanaAltana's third-quarter profits rose 42 percent, beating Wall Street's expectations, but analysts were split in their rating of the stock going forward. FORTUNE... time to save the economy from the weak housing market, says Fortune's Nelson Schwartz. ( more ) Short the CEO, buy the stock? 11:55am: Options backdating has cost a few CEOs their jobs. But sometimes uncertainty creates a buying opportunity, reports ... CVS Q3 2006 Earnings Call Transcript... we've outlined for you under the caption "Cautionary Statements" concerning forward-looking statements in our Annual Report on Form 10-K for the 2005 fiscal year ending December 31, 2005, and in our quarterly report on Form 10-Q for the quarter ...
|
